EUVIMEDEUVIMED entdecken
Crossref

CCR5 promoter region polymorphisms in systemic lupus erythematosus

Juliana da Silveira Schauren iD, Amanda Henrique de Oliveira iD, Camila Rosat Consiglio iD, Odirlei André Monticielo iD, Ricardo Machado Xavier iD, Natália Schneider Nunes iD, Joel Henrique Ellwanger iD, José Artur Bogo Chies iD

International Journal of Immunogenetics · 2024

DOI: 10.1111/iji.12646 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Immunogenetics, 2024. Verfasst von Juliana da Silveira Schauren und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunobiology and Immunogenetics, Department of Genetics, Postgraduate Program in Genetics and Molecular Biology (PPGBM), Universidade …. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Nephritis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 90 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated the impacts of CCR5 promoter region polymorphisms on the development of systemic lupus erythematosus (SLE) by comparing CCR5 genotypes and haplotypes from SLE patients with ethnically matched controls. A total of 382 SLE patients (289 European‐derived and 93 African‐derived) and 375 controls (243 European‐derived and 132 African‐derived) were genotyped for the CCR2‐64I G > A (rs1799864), CCR5‐59353 C > T (rs1799988), CCR5‐59356 C > T (rs41469351), CCR5‐59402 A > G (rs1800023) and CCR5‐59653 C > T (rs1800024) polymorphisms through polymerase chain reaction‐restriction fragment length polymorphism and direct sequencing. Previous data from CCR5Δ32 analysis was included in the study to infer the CCR5 haplotypes and as a possible confounding factor in the binary logistic regression. European‐derived patients showed a higher frequency of CCR5 wild‐type genotype (conversely, a reduced frequency of Δ32 allele) and a reduced frequency of the HHG*2 haplotype compared to controls; both factors significantly affecting disease risk [ p = .003 (OR 3.5, 95%CI 1.6–7.5) and 2.0% vs. 7.2% (residual p = 2.9E − 5), respectively]. Additionally, the HHA/HHB, HHC and HHG*2 haplotype frequencies differed between African‐derived patients and controls [10% vs. 20.5% (residual p = .003), 29.4% vs. 17.4% (residual p = .003) and 3.9% vs. 0.8% (residual p = .023), respectively]. Considering the clinical manifestations of the disease, the CCR5Δ32 presence was confirmed as a susceptibility factor to class IV nephritis in the African‐derived group and when all patients were grouped for comparison [ p corrected = .012 (OR 3.0; 95%CI 3.0–333.3) and p corrected = .0006 (OR 6.8; 95%CI 1.9–24.8), respectively]. In conclusion, this study indicates that CCR5 promoter polymorphisms are important disease modifiers in SLE. Present data reinforces the CCR5Δ32 polymorphism as a protective factor for the development of the disease in European‐derived patients and as a susceptibility factor for class IV nephritis in African‐derived patients. Furthermore, we also described a reduced frequency of HHA/HHB and an increased frequency of HHC and HHG*2 haplotypes in African‐derived patients, which could modify the CCR5 protein expression in specific cell subsets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicNephritisHumansGenetic Predisposition to DiseasePolymorphism, GeneticGenotypeReceptors, CCR5Promoter Regions, GeneticGene FrequencyPolymorphism, Single Nucleotide

Stichwörter der Autor:innen

Brazilian populationCCR5 promoter polymorphismsimmunogeneticsinflammationrs333systemic lupus erythematosus

Substanzen

Receptors, CCR5CCR5 protein, human

Autor:innen und Institutionen

  • Laboratory of Immunobiology and Immunogenetics, Department of Genetics, Postgraduate Program in Genetics and Molecular Biology (PPGBM), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul,…
  • Postgraduate Program in Gastroenterology and Hepatology Sciences, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil.
  • Division of Rheumatology, Department of Internal Medicine, Hospital de Clínicas de Porto Alegre (HCPA), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil.
  • Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

ORCID-Profile: Juliana da Silveira Schauren, Amanda Henrique de Oliveira, Camila Rosat Consiglio, Odirlei André Monticielo, Ricardo Machado Xavier, Natália Schneider Nunes, Joel Henrique Ellwanger, José Artur Bogo Chies

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Schauren, J. D. S., de Oliveira, A. H., Consiglio, C. R., Monticielo, O. A., Xavier, R. M., Nunes, N. S., Ellwanger, J. H., & Chies, J. A. B. (2024). CCR5 promoter region polymorphisms in systemic lupus erythematosus. International Journal of Immunogenetics. https://doi.org/10.1111/iji.12646

Vancouver

Schauren JDS, de Oliveira AH, Consiglio CR, Monticielo OA, Xavier RM, Nunes NS, et al. CCR5 promoter region polymorphisms in systemic lupus erythematosus. International Journal of Immunogenetics. 2024. doi:10.1111/iji.12646

BibTeX
@article{Schauren2024,
  author = {Schauren, Juliana da Silveira and de Oliveira, Amanda Henrique and Consiglio, Camila Rosat and Monticielo, Odirlei André and Xavier, Ricardo Machado and Nunes, Natália Schneider and Ellwanger, Joel Henrique and Chies, José Artur Bogo},
  title = {CCR5 promoter region polymorphisms in systemic lupus erythematosus},
  journal = {International Journal of Immunogenetics},
  year = {2024},
  doi = {10.1111/iji.12646}
}
Kostenlos starten →